ShortageWatch

Fondaparinux Sodium Injection shortage

To Be Discontinued

Fondaparinux Sodium Injection is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category
Hematology
Dosage form
Injection
Routes
SUBCUTANEOUS
Last updated
09/29/2025

Strength variants

  • Not specified

Need sourcing help for Fondaparinux Sodium Injection?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Hematology

Heparin Sodium Injection

Currently in Shortage
Category
Hematology
Reason
Requirements related to complying with good manufacturing practices
Updated
04/07/2026

Heparin Sodium Injection

Currently in Shortage
Category
Hematology
Reason
Requirements related to complying with good manufacturing practices
Updated
04/07/2026

Desmopressin Acetate Spray

Currently in Shortage
Category
Hematology
Reason
Not specified
Updated
04/02/2026

Heparin Sodium Injection

Currently in Shortage
Category
Hematology
Reason
Not specified
Updated
04/02/2026

Heparin Sodium Injection

Currently in Shortage
Category
Hematology
Reason
Not specified
Updated
04/02/2026

Heparin Sodium Injection

Currently in Shortage
Category
Hematology
Reason
Discontinuation of the manufacture of the drug
Updated
04/01/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.